Sugi Predict

Sugi Predict / Compounds / SCHEMBL18989265

SCHEMBL18989265

SCHEMBL18989265

CC1CC(=NNC(=O)O)CC(C)O1

nearest known ligand 0.35

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.35
▸ TP53 P04637 1/20 0.33
▸ LMNA P02545 2/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ RECQL P46063 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.31
▸ GAA P10253 2/20 0.31
▸ POLB P06746 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18989284 0.79 ALDH1A1 (0.36) ALDH1A1TP53LMNAKDM4ERECQL
SCHEMBL31327116 0.78 ALDH1A1 (0.54) ALDH1A1KDM4ERECQLMEN1KMT2A
SCHEMBL31327114 0.78 ALDH1A1 (0.54) ALDH1A1KDM4ERECQLMEN1KMT2A
SCHEMBL20583598 0.74 ALDH1A1 (0.31) ALDH1A1KMT2A
SCHEMBL25380152 0.68 TSHR (0.32) ALDH1A1SMN1; SMN2
SCHEMBL25380149 0.68 TSHR (0.32) ALDH1A1SMN1; SMN2
SCHEMBL7354510 0.66 KDM4E (0.50) ALDH1A1LMNAKDM4ERECQLKMT2A
SCHEMBL7345401 0.66 — —
SCHEMBL20583468 0.65 ALDH1A1 (0.35) ALDH1A1LMNAKDM4ERECQLGAA
SCHEMBL7351663 0.64 KDM4E (0.53) ALDH1A1KDM4EMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11826351-B2 Compounds useful as kinase inhibitors LOXO ONCOLOGY INC. (US) 2023-11-28 — — US disclosed
US-20230372298-A1 COMPOUNDS USEFUL AS KINASE INHIBITORS LOXO ONCOLOGY, INC. 2023-11-23 — — US disclosed
US-20220062239-A1 COMPOUNDS USEFUL AS KINASE INHIBITORS LOXO ONCOLOGY, INC. 2022-03-03 — — US disclosed
US-20210093611-A1 COMPOUNDS USEFUL AS KINASE INHIBITORS LOXO ONCOLOGY, INC. 2021-04-01 — — US disclosed
EP-3782994-A1 COMPOUNDS USEFUL AS KINASE INHIBITORS Loxo Oncology, Inc. (US) 2021-02-24 — — EP disclosed
US-10918622-B2 Compounds useful as kinase inhibitors LOXO ONCOLOGY, INC. (US) 2021-02-16 — — US disclosed
EP-3390395-B1 COMPOUNDS USEFUL AS KINASE INHIBITORS LOXO ONCOLOGY INC (US) 2020-09-09 — — EP disclosed
US-20200276162-A1 COMPOUNDS USEFUL AS KINASE INHIBITORS LOXO ONCOLOGY, INC. 2020-09-03 — — US disclosed
US-10695323-B2 Compounds useful as kinase inhibitors LOXO ONCOLOGY, INC. (US) 2020-06-30 — — US disclosed
US-10464905-B2 Compounds useful as kinase inhibitors LOXO ONCOLOGY INC. (US) 2019-11-05 — — US disclosed
US-10342780-B2 Compounds useful as kinase inhibitors LOXO ONCOLOGY, INC. (US) 2019-07-09 — — US disclosed
US-20190135762-A1 COMPOUNDS USEFUL AS KINASE INHIBITORS LOXO ONCOLOGY, INC. 2019-05-09 — — US disclosed
US-20190000806-A1 COMPOUNDS USEFUL AS KINASE INHIBITORS LOXO ONCOLOGY, INC. 2019-01-03 — — US disclosed
US-20180362512-A1 COMPOUNDS USEFUL AS KINASE INHIBITORS LOXO ONCOLOGY, INC. 2018-12-20 — — US disclosed
EP-3390395-A1 COMPOUNDS USEFUL AS KINASE INHIBITORS Loxo Oncology Inc. (US) 2018-10-24 — — EP disclosed
WO-2017103611-A1 COMPOUNDS USEFUL AS KINASE INHIBITORS REDX PHARMA PLC (GB) 2017-06-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220062239-A1 COMPOUNDS USEFUL AS KINASE INHIBITORS BTK, ABL1, LCK ALDH1A1 4454/4885TP53 899/4885LMNA 4225/4885
US-20180362512-A1 COMPOUNDS USEFUL AS KINASE INHIBITORS BTK, ABL1, LCK ALDH1A1 4454/4885TP53 899/4885LMNA 4225/4885
US-20190135762-A1 COMPOUNDS USEFUL AS KINASE INHIBITORS BTK, ABL1, LCK ALDH1A1 4454/4885TP53 899/4885LMNA 4225/4885
US-10918622-B2 Compounds useful as kinase inhibitors BTK, ABL1, LCK ALDH1A1 4454/4885TP53 899/4885LMNA 4225/4885
US-20200276162-A1 COMPOUNDS USEFUL AS KINASE INHIBITORS BTK, ABL1, LCK ALDH1A1 4454/4885TP53 899/4885LMNA 4225/4885
US-11826351-B2 Compounds useful as kinase inhibitors BTK, ABL1, LCK ALDH1A1 4454/4885TP53 899/4885LMNA 4225/4885
US-10695323-B2 Compounds useful as kinase inhibitors BTK, ABL1, LCK ALDH1A1 4454/4885TP53 899/4885LMNA 4225/4885
US-20230372298-A1 COMPOUNDS USEFUL AS KINASE INHIBITORS BTK, ABL1, LCK ALDH1A1 4454/4885TP53 899/4885LMNA 4225/4885
US-20210093611-A1 COMPOUNDS USEFUL AS KINASE INHIBITORS BTK, ABL1, LCK ALDH1A1 4454/4885TP53 899/4885LMNA 4225/4885
US-10464905-B2 Compounds useful as kinase inhibitors BTK, ABL1, LCK ALDH1A1 4454/4885TP53 899/4885LMNA 4225/4885
US-10342780-B2 Compounds useful as kinase inhibitors BTK, ABL1, LCK ALDH1A1 4454/4885TP53 899/4885LMNA 4225/4885
US-20190000806-A1 COMPOUNDS USEFUL AS KINASE INHIBITORS BTK, ABL1, LCK ALDH1A1 4454/4885TP53 899/4885LMNA 4225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.